Anticorps Recombinant de lapin anti-KIR2DS4/CD158i
KIR2DS4/CD158i Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC
Conjugaison
Non conjugué
CloneNo.
242656E10
N° de cat : 98339-3-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en cytométrie | leucocyte de sang périphérique humain, |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
98339-3-RR cible KIR2DS4/CD158i dans les applications de FC et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | KIR2DS4/CD158i Protéine recombinante Eg4353 |
| Nom complet | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 |
| Masse moléculaire calculée | 34 kDa |
| Numéro d’acquisition GenBank | NM_012314.6 |
| Symbole du gène | KIR2DS4 |
| Identification du gène (NCBI) | 3809 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS with 0.09% sodium azide |
| Conditions de stockage | Store at 2 - 8°C. Stable for one year after shipment. |
Informations générales
KIR2DS4 (also known as CD158i) is a member of the killer cell immunoglobulin-like receptor (KIR) family. KIRs are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. KIRs are mainly involved in inhibiting NK killing (inhibitory KIRs) via interaction with MHC class I molecules. KIR2DS4 has been reported to be an activating KIR and recognize the HLA-Cw4 protein.
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for KIR2DS4/CD158i antibody 98339-3-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
